Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach

Alfredo Bellon; K Nguyen

doi:10.5498/wjp.v11.i7.316

Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	316-324
Journal	World Journal of Psychiatry
Volume	11
Issue number	7
DOIs	https://doi.org/10.5498/wjp.v11.i7.316
State	Published - Jul 19 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5498/wjp.v11.i7.316

Cite this

@article{8ac5453e78a04c748eb79cbbd876e94f,

title = "Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach",

author = "Alfredo Bellon and K Nguyen",

year = "2021",

month = jul,

day = "19",

doi = "10.5498/wjp.v11.i7.316",

language = "English (US)",

volume = "11",

pages = "316--324",

journal = "World Journal of Psychiatry",

issn = "2220-3206",

publisher = "Baishideng Publishing Group",

number = "7",

}

TY - JOUR

T1 - Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach

AU - Bellon, Alfredo

AU - Nguyen, K

PY - 2021/7/19

Y1 - 2021/7/19

U2 - 10.5498/wjp.v11.i7.316

DO - 10.5498/wjp.v11.i7.316

M3 - Article

C2 - 34327124

SN - 2220-3206

VL - 11

SP - 316

EP - 324

JO - World Journal of Psychiatry

JF - World Journal of Psychiatry

IS - 7

ER -